|
2026-03-31 |
2026-03-30 |
B
Purchase
|
CFO
Officer
|
11,064
+46.9%
498.27
US$3,789,802
|
11,064
+46.9%
|
498.27
|
US$3,789,802
|
|
|
2025-12-17 |
2025-12-16 |
B
Purchase
|
Non-Executive Director
|
50,456
-13.1%
136.67
US$155,935
|
50,456
-13.1%
|
136.67
|
US$155,935
|
|
|
2025-12-17 |
2025-12-16 |
B
Purchase
|
Chief Medical Officer
Officer
|
11,355
+23.2%
19.83
US$4,991,875
|
11,355
+23.2%
|
19.83
|
US$4,991,875
|
|
|
2025-12-15 |
2025-12-15 |
B
Purchase
|
Chief Commercial Officer
Officer
|
100
+0.1%
1.60
US$160
|
100
+0.1%
|
1.60
|
US$160
|
|
|
2025-12-15 |
2025-12-15 |
B
Purchase
|
Chief Commercial Officer
Officer
|
12,000
+20.2%
1.62
US$19,439
|
12,000
+20.2%
|
1.62
|
US$19,439
|
|
|
2025-12-15 |
2025-12-15 |
B
Purchase
|
CEO
Executive Director
|
32,000
+5.3%
1.59
US$50,880
|
32,000
+5.3%
|
1.59
|
US$50,880
|
|
|
2025-12-15 |
2025-12-15 |
B
Purchase
|
CFO
Officer
|
2,500
+55.6%
1.79
US$4,475
|
2,500
+55.6%
|
1.79
|
US$4,475
|
|
|
2025-12-15 |
2025-12-15 |
B
Purchase
|
CFO
Officer
|
2,500
+55.6%
1.79
US$4,462
|
2,500
+55.6%
|
1.79
|
US$4,462
|
|
|
2025-12-15 |
2025-12-15 |
B
Purchase
|
CFO
Officer
|
40,000
+10.6%
1.77
US$70,640
|
40,000
+10.6%
|
1.77
|
US$70,640
|
|
|
2025-06-26 |
2025-06-25 |
B
Purchase
|
Chief Medical Officer
Officer
|
2,500
+19.2%
4.38
US$10,939
|
2,500
+19.2%
|
4.38
|
US$10,939
|
|
|
2025-06-24 |
2025-06-24 |
B
Purchase
|
CFO
Officer
|
5,000
+1.9%
4.05
US$20,250
|
5,000
+1.9%
|
4.05
|
US$20,250
|
|
|
2025-06-23 |
2025-06-13 |
B
Purchase
|
Non-Executive Director
|
1,230,769
+17.1%
3.25
US$3,999,999
|
1,230,769
+17.1%
|
3.25
|
US$3,999,999
|
|
|
2025-06-23 |
2025-06-13 |
B
Purchase
|
Non-Executive Director
|
3,076
+8.9%
3.25
US$9,997
|
3,076
+8.9%
|
3.25
|
US$9,997
|
|
|
2025-04-01 |
2025-03-31 |
B
Purchase
|
Non-Executive Director
|
6,758
+8.7%
2.92
US$19,733
|
6,758
+8.7%
|
2.92
|
US$19,733
|
|
|
2025-03-31 |
2025-03-27 |
B
Purchase
|
CEO
Executive Director
|
12,302
+5.8%
2.85
US$34,999
|
12,302
+5.8%
|
2.85
|
US$34,999
|
|
|
2025-03-28 |
2025-03-26 |
B
Purchase
|
CFO
Officer
|
10,000
+76.9%
2.88
US$28,800
|
10,000
+76.9%
|
2.88
|
US$28,800
|
|
|
2025-03-28 |
2025-03-26 |
B
Purchase
|
CFO
Officer
|
10,000
+4.4%
2.89
US$28,900
|
10,000
+4.4%
|
2.89
|
US$28,900
|
|
|
2025-02-20 |
2025-02-18 |
B
Purchase
|
Non-Executive Director
|
10,000
+14.9%
4.70
US$47,000
|
10,000
+14.9%
|
4.70
|
US$47,000
|
|
|
2024-12-18 |
2024-12-18 |
B
Purchase
|
CFO
Officer
|
10,000
+7.1%
4.29
US$42,900
|
10,000
+7.1%
|
4.29
|
US$42,900
|
|
|
2024-12-12 |
2024-12-12 |
B
Purchase
|
CFO
Officer
|
9,000
+6.8%
4.60
US$41,400
|
9,000
+6.8%
|
4.60
|
US$41,400
|
|
|
2024-09-24 |
2024-09-24 |
B
Purchase
|
Non-Executive Director
|
4,259
+11.4%
4.70
US$20,017
|
4,259
+11.4%
|
4.70
|
US$20,017
|
|
|
2025-02-19 |
2024-06-25 |
B
Purchase
|
Non-Executive Director
|
1,250,000
+21.0%
4.00
US$5,000,000
|
1,250,000
+21.0%
|
4.00
|
US$5,000,000
|
|
|
2024-06-27 |
2024-06-25 |
B
Purchase
|
Non-Executive Director
|
4,815
+14.7%
4.15
US$19,982
|
4,815
+14.7%
|
4.15
|
US$19,982
|
|
|
2024-06-14 |
2024-06-14 |
B
Purchase
|
Chief Medical Officer
Officer
|
300
+27.9%
3.97
US$1,191
|
300
+27.9%
|
3.97
|
US$1,191
|
|
|
2024-06-14 |
2024-06-14 |
B
Purchase
|
Chief Medical Officer
Officer
|
3,000
+30.0%
3.91
US$11,725
|
3,000
+30.0%
|
3.91
|
US$11,725
|
|
|
2024-06-14 |
2024-06-14 |
B
Purchase
|
Chief Medical Officer
Officer
|
300
+0.6%
3.96
US$1,188
|
300
+0.6%
|
3.96
|
US$1,188
|
|
|
2024-06-14 |
2024-06-14 |
B
Purchase
|
Chief Medical Officer
Officer
|
4,000
+8.0%
3.91
US$15,640
|
4,000
+8.0%
|
3.91
|
US$15,640
|
|
|
2024-06-14 |
2024-06-14 |
B
Purchase
|
CFO
Officer
|
40,000
+inf%
4.04
US$161,568
|
40,000
+inf%
|
4.04
|
US$161,568
|
|
|
2024-05-31 |
2024-05-29 |
B
Purchase
|
CFO
Officer
|
451
+0.4%
3.50
US$1,578
|
451
+0.4%
|
3.50
|
US$1,578
|
|
|
2024-05-28 |
2024-05-24 |
B
Purchase
|
CFO
Officer
|
2,942
+29.3%
3.23
US$9,503
|
2,942
+29.3%
|
3.23
|
US$9,503
|
|
|
2024-05-28 |
2024-05-23 |
B
Purchase
|
CFO
Officer
|
58
+0.6%
2.85
US$165
|
58
+0.6%
|
2.85
|
US$165
|
|
|
2024-05-28 |
2024-05-23 |
B
Purchase
|
Chief Medical Officer
Officer
|
6,000
+13.6%
2.68
US$16,058
|
6,000
+13.6%
|
2.68
|
US$16,058
|
|
|
2024-05-28 |
2024-05-23 |
B
Purchase
|
Chief Medical Officer
Officer
|
1,500
+3.5%
2.72
US$4,080
|
1,500
+3.5%
|
2.72
|
US$4,080
|
|
|
2024-03-29 |
2024-03-28 |
B
Purchase
|
Chief Medical Officer
Officer
|
500
+86.8%
2.55
US$1,275
|
500
+86.8%
|
2.55
|
US$1,275
|
|
|
2024-03-19 |
2024-03-15 |
B
Purchase
|
CFO
Officer
|
20,000
+inf%
1.69
US$33,830
|
20,000
+inf%
|
1.69
|
US$33,830
|
|
|
2024-03-18 |
2024-03-14 |
B
Purchase
|
Chief Medical Officer
Officer
|
10,000
+inf%
1.88
US$18,800
|
10,000
+inf%
|
1.88
|
US$18,800
|
|
|
2024-03-08 |
2024-03-08 |
B
Purchase
|
CFO
Officer
|
50,000
+70.5%
1.93
US$96,345
|
50,000
+70.5%
|
1.93
|
US$96,345
|
|
|
2024-03-14 |
2024-03-07 |
B
Purchase
|
Non-Executive Director
|
36,503
+46.2%
1.91
US$69,859
|
36,503
+46.2%
|
1.91
|
US$69,859
|
|
|
2024-03-11 |
2024-03-07 |
B
Purchase
|
Chief Medical Officer
Officer
|
500
+inf%
1.85
US$925
|
500
+inf%
|
1.85
|
US$925
|
|
|
2024-02-28 |
2024-02-26 |
B
Purchase
|
CEO
Executive Director
|
5,000
+177.5%
1.68
US$8,400
|
5,000
+177.5%
|
1.68
|
US$8,400
|
|
|
2024-02-27 |
2024-02-26 |
B
Purchase
|
Chief Medical Officer
Officer
|
2,000
+4.9%
1.70
US$3,400
|
2,000
+4.9%
|
1.70
|
US$3,400
|
|
|
2024-02-27 |
2024-02-23 |
B
Purchase
|
Chief Medical Officer
Officer
|
6,000
+17.4%
1.69
US$10,140
|
6,000
+17.4%
|
1.69
|
US$10,140
|
|
|
2024-02-21 |
2024-02-16 |
B
Purchase
|
Chief Medical Officer
Officer
|
7,000
+25.4%
1.31
US$9,142
|
7,000
+25.4%
|
1.31
|
US$9,142
|
|
|
2024-02-20 |
2024-02-16 |
B
Purchase
|
CFO
Officer
|
4,500
+inf%
1.37
US$6,165
|
4,500
+inf%
|
1.37
|
US$6,165
|
|
|
2024-02-20 |
2024-02-16 |
B
Purchase
|
CFO
Officer
|
4,500
+inf%
1.37
US$6,165
|
4,500
+inf%
|
1.37
|
US$6,165
|
|
|
2024-02-20 |
2024-02-16 |
B
Purchase
|
CFO
Officer
|
41,900
+144.5%
1.30
US$54,411
|
41,900
+144.5%
|
1.30
|
US$54,411
|
|
|
2023-07-06 |
2023-07-03 |
B
Purchase
|
Chief Medical Officer
Officer
|
5,000
+22.2%
1.90
US$9,500
|
5,000
+22.2%
|
1.90
|
US$9,500
|
|
|
2024-03-19 |
2022-07-22 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
3,157,895
+113.4%
3.80
US$12,000,001
|
3,157,895
+113.4%
|
3.80
|
US$12,000,001
|
|
|
2024-03-14 |
2022-07-22 |
B
Purchase
|
Non-Executive Director
|
78,947
+inf%
3.80
US$299,999
|
78,947
+inf%
|
3.80
|
US$299,999
|
|
|
2022-05-19 |
2022-05-19 |
B
Purchase
|
Sr VP, Clinic Development
Officer
|
300
+1.3%
2.95
US$884
|
300
+1.3%
|
2.95
|
US$884
|
|
|
2022-05-19 |
2022-05-18 |
B
Purchase
|
Sr VP, Clinic Development
Officer
|
200
+0.9%
2.86
US$572
|
200
+0.9%
|
2.86
|
US$572
|
|
|
2022-05-19 |
2022-05-17 |
B
Purchase
|
Sr VP, Clinic Development
Officer
|
1,000
+4.8%
3.41
US$3,406
|
1,000
+4.8%
|
3.41
|
US$3,406
|
|
|
2022-05-06 |
2022-05-04 |
B
Purchase
|
Non-Executive Director
|
25,000
+325.0%
3.80
US$95,000
|
25,000
+325.0%
|
3.80
|
US$95,000
|
|
|
2022-05-06 |
2022-05-04 |
B
Purchase
|
Sr VP, Clinic Development
Officer
|
21,052
+inf%
3.80
US$79,998
|
21,052
+inf%
|
3.80
|
US$79,998
|
|
|
2022-05-06 |
2022-05-04 |
B
Purchase
|
Non-Executive Director
|
52,631
+inf%
3.80
US$199,998
|
52,631
+inf%
|
3.80
|
US$199,998
|
|
|
2024-03-19 |
2021-10-15 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
769,231
+38.2%
6.50
US$5,000,002
|
769,231
+38.2%
|
6.50
|
US$5,000,002
|
|
|
2022-05-06 |
2021-10-15 |
B
Purchase
|
Non-Executive Director
|
7,693
+inf%
6.50
US$50,004
|
7,693
+inf%
|
6.50
|
US$50,004
|
|
|
2020-10-14 |
2020-10-13 |
PP
Planned purchase
|
Large shareholder
|
2,500
+0.1%
23.35
US$58,380
|
2,500
+0.1%
|
23.35
|
US$58,380
|
|
|
2020-10-14 |
2020-10-12 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$58,112
|
125,000
+0.1%
|
0.46
|
US$58,112
|
|
|
2020-10-08 |
2020-10-07 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.41
US$50,925
|
125,000
+0.1%
|
0.41
|
US$50,925
|
|
|
2020-10-07 |
2020-10-06 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.42
US$52,900
|
125,000
+0.1%
|
0.42
|
US$52,900
|
|
|
2020-10-07 |
2020-10-05 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,175
|
125,000
+0.1%
|
0.46
|
US$57,175
|
|
|
2020-10-05 |
2020-10-02 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.45
US$56,362
|
125,000
+0.1%
|
0.45
|
US$56,362
|
|
|
2020-10-02 |
2020-10-01 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.44
US$55,038
|
125,000
+0.1%
|
0.44
|
US$55,038
|
|
|
2020-10-02 |
2020-09-30 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.44
US$54,538
|
125,000
+0.1%
|
0.44
|
US$54,538
|
|
|
2020-09-28 |
2020-09-25 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.45
US$55,738
|
125,000
+0.1%
|
0.45
|
US$55,738
|
|
|
2020-09-25 |
2020-09-24 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.44
US$55,400
|
125,000
+0.1%
|
0.44
|
US$55,400
|
|
|
2020-09-25 |
2020-09-23 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,138
|
125,000
+0.1%
|
0.46
|
US$57,138
|
|
|
2020-09-23 |
2020-09-22 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,362
|
125,000
+0.1%
|
0.46
|
US$57,362
|
|
|
2020-09-23 |
2020-09-21 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,362
|
125,000
+0.1%
|
0.46
|
US$57,362
|
|
|
2020-09-21 |
2020-09-18 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,562
|
125,000
+0.1%
|
0.46
|
US$57,562
|
|
|
2020-09-18 |
2020-09-17 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,712
|
125,000
+0.1%
|
0.46
|
US$57,712
|
|
|
2020-09-18 |
2020-09-16 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,162
|
125,000
+0.1%
|
0.46
|
US$57,162
|
|
|
2020-09-16 |
2020-09-15 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.45
US$56,412
|
125,000
+0.1%
|
0.45
|
US$56,412
|
|
|
2020-09-16 |
2020-09-14 |
PP
Planned purchase
|
Large shareholder
|
125,000
+0.1%
0.46
US$57,550
|
125,000
+0.1%
|
0.46
|
US$57,550
|
|
